|
April 30, 2009 - Theralase Technologies Inc. (TSX VENTURE:
TLT) today announced financial results for the three and twelve months
ended December 31, 2008.Revenue for the three months
ended December 31, 2008 was $779,600, an increase of 104% compared to
$382,993 in the same period in 2007.
Total 2008 annual revenue increased by 39% to $2,168,411 compared to
$1,559,850 in 2007.
Canadian product sales in 2008 increased 58% year-over-year to $1,424,441
while US product sales decreased by 28% year-over-year to $469,099. The strong
growth in Canadian product sales and the subsequent decrease in American product
sales is a reflection of the Company focusing its sales and marketing
initiatives on the Canadian market due to the weakening US economy in the 2nd
half of 2008.
About Theralase;
Theralase Technologies Inc. is focused on a two-part strategy:
1. Production, marketing and distribution of the Theralase Super-Pulsed Laser
Technologies for sale to health care practitioners that are focused on the
treatment of chronic pain, sports injuries and wounds.
2. Commercialization of patented cancer treatment through progressive
research, clinical trials and advancement of new technology in the direct
destruction of cancers.
Contact:
Web Site:
http://www.theralase.com.
Source. |
